Pay in 4 interest-free payments of $7.36 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
What they found: Favorable safety profile , no serious adverse events at doses up to 100 g/kg Preliminary efficacy signals positive The program stopped before Phase 3 for unknown commercial reasons (the program passed through several sponsor rotations and no one ultimately carried it through) Why it matters: These are the only published clinical data in humans that we have
This ratio works best for lower doses in the early titration phases
Herrera F, Martin V, Garca-Santos G, Rodriguez-Blanco J, Antoln I, Rodriguez C
Liang DL, et al
Theyre beneficial
US$ 25.64
US$ 22.05
US$ 28.04
US$ 22.07
US$ 23.38
US$ 25.09
US$ 26.16
US$ 24.90
